See the DrugPatentWatch profile for Thalidomide
What is thalidomide used for?
Thalidomide is used in the treatment of multiple myeloma (a cancer of plasma cells) in certain clinical settings [1]. It has also been used in other serious conditions, depending on the country and the specific indication being followed [2].
What conditions does thalidomide treat (common indications)?
The main well-established use is multiple myeloma, typically in combination regimens under specialist care [1]. It is also used for other indications in some settings, but those uses vary by regulation and prescribing guidance [2].
How is it used for multiple myeloma?
For multiple myeloma, thalidomide is used as part of therapy designed to control the disease [1]. The exact regimen depends on patient factors and local treatment protocols.
What are the key safety concerns tied to these uses?
Thalidomide has major safety risks, most notably severe birth defects if taken during pregnancy [1]. Because of this, its use is tightly controlled and prescribing typically follows pregnancy-prevention and monitoring requirements [1][2].
Where can you find the exact “uses” wording for a specific country?
Because “uses” phrasing is regulatory and varies by jurisdiction, the most accurate answer comes from your local product label (SmPC/PI) or a national medicines authority database. Those documents list the approved indications and any restrictions [2].
Sources:
[1] https://www.ema.europa.eu/en/medicines/human/EPAR/thalidomide
[2] https://www.nhs.uk/medicines/thalidomide/